Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319856.
- Also identified by DOI 10.1056/EVIDra2200118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune Modulation in Sepsis, ARDS, and Covid-19Leligdowicz et al. consider the history and future of immunomodulating therapies in sepsis and ARDS, including ARDS due to Covid-19, and remark on the larger challenge of clinical research on therapies for syndromes with profound clinical and biologic heterogeneity.
Medical subject headings
- COVID-19
- Sepsis
- Respiratory Distress Syndrome